Message for the clinic
Pulmonary vein isolation (PVI) is established as the cornerstone for
treating atrial fibrillation (AF). However, the low power longer
duration (LPLD) ablation always accompanied by a higher recurrence and
the clinical benefits of high power shorter duration (HPSD) ablation
were inconsistent. In our analysis, we found that the approach of HPSD
seen to be effective and safe for AF treatment.